BeOne Medicines (ONC) Profit After Tax (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn |
| 10 | BeOne Medicines | - | - | 1.35 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 241.88% |
| Dec 31, 2025 | -46.73% |
| Sep 30, 2025 | 32.36% |
| Jun 30, 2025 | 7,326.77% |
| Mar 31, 2025 | 100.84% |
| Dec 31, 2024 | -25.16% |
| Sep 30, 2024 | -0.78% |
| Jun 30, 2024 | 52.06% |
| Mar 31, 2024 | 31.67% |
| Dec 31, 2023 | -270.63% |
| Sep 30, 2023 | 156.52% |
| Jun 30, 2023 | -9.39% |
| Mar 31, 2023 | 21.76% |
| Dec 31, 2022 | 20.13% |
| Sep 30, 2022 | 1.44% |
| Jun 30, 2022 | -29.99% |
| Mar 31, 2022 | 26.32% |
| Dec 31, 2021 | -34.82% |
| Sep 30, 2021 | 8.79% |
| Jun 30, 2021 | -822.37% |
| Mar 31, 2021 | 114.07% |
| Dec 31, 2020 | -11.15% |
| Sep 30, 2020 | -26.44% |
| Jun 30, 2020 | 7.84% |
| Mar 31, 2020 | 5.96% |
| Dec 31, 2019 | -26.26% |
| Sep 30, 2019 | -259.19% |
| Jun 30, 2019 | 48.96% |
| Mar 31, 2019 | 37.15% |
| Dec 31, 2018 | -85.18% |
| Sep 30, 2018 | 8.68% |
| Jun 30, 2018 | -50.04% |
| Mar 31, 2018 | -5.83% |
| Dec 31, 2017 | -184.69% |
| Sep 30, 2017 | 293.28% |
| Jun 30, 2017 | -19.87% |
| Mar 31, 2017 | -34.64% |
| Dec 31, 2016 | -5.93% |
| Sep 30, 2016 | -47.13% |
| Jun 30, 2016 | -9.65% |
| Mar 31, 2016 | 19.26% |
| Dec 31, 2015 | -94.66% |
| Sep 30, 2015 | -148.17% |
| Jun 30, 2015 | 44.76% |